VIVIMEDLAB

Vivimed Labs Share PriceVivimed Labs

₹6.95
-0.35 (-4.79%)
As on 22 March, 2023 | 22:04 BSE: 532660 NSE: VIVIMEDLAB

Vivimed Labs Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Vivimed Labs

Start SIP

Vivimed Labs Share Price

  • Over 1 Month -17.75%
  • Over 3 Month -37.67%
  • Over 6 Month -34.74%
  • Over 1 Year -60.51%

Vivimed Labs Key Statistics

P/E Ratio -0.7
PEG Ratio 0.1
Market Cap Cr 58
Price to Book Ratio 0.2
EPS -8.2
Dividend 0
Relative Strength Index 18.01
Money Flow Index 14.55
MACD Signal -0.59
Average True Range 0.54

Vivimed Labs Investment Rating

  • Master Rating:
  • Vivimed Labs has an operating revenue of Rs. 211.20 Cr. on a trailing 12-month basis. An annual revenue de-growth of -73% needs improvement, Pre-tax margin of -27% needs improvement, ROE of -20% is poor and needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 39 which is a POOR score indicating inconsistency in earnings, a RS Rating of 7 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 88 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Vivimed Labs Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 51394753
Operating Expenses Qtr Cr 57495655
Operating Profit Qtr Cr -6-10-9-2
Depreciation Qtr Cr 4445
Interest Qtr Cr 99910
Tax Qtr Cr 0003
Net Profit Qtr Cr -19-22-22-19

Vivimed Labs Technicals

EMA & SMA

Current Price
₹6.95
-0.35 (-4.79%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 9.26
  • 50 Day
  • 10
  • 100 Day
  • 10.4
  • 200 Day
  • 11.77
  • 20 Day
  • 9.71
  • 50 Day
  • 10.44
  • 100 Day
  • 10.17
  • 200 Day
  • 11.07

Vivimed Labs Resistance and Support

PIVOT
₹7.3
Resistance
First Resistance 7.3
Second Resistance 7.3
Third Resistance 7.3
RSI 18.02
MFI 14.55
MACD Single Line -0.59
MACD -0.92
Support
First Resistance 7.3
Second Resistance 7.3
Third Resistance 7.3

Vivimed Labs Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 132,770 13,277,000 100
Week 132,770 13,277,000 100
1 Month
6 Month 105,232 8,868,935 84.28

Vivimed Labs Result Highlights

Vivimed Labs Synopsis

NSE-Medical-Diversified

Vivimed Labs is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 218.37 Cr. and Equity Capital is Rs. 16.58 Cr. for the Year ended 31/03/2022. Vivimed Labs Ltd. is a Public Limited Listed company incorporated on 22/09/1988 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L02411KA1988PLC009465 and registration number is 009465.
Market Cap 58
Sales 190
Shares in Float 6.55
No of funds 5
Yield
Book Value 0.14
U/D Vol ratio 0.3
LTDebt / Equity 14
Alpha -0.38
Beta 0.64

Vivimed Labs

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 20.96%20.96%20.96%
Foreign Portfolio Investors 1.64%1.64%1.64%
Individual Investors 57.03%57.64%57.38%
Others 20.37%19.76%20.02%

Vivimed Labs Management

Name Designation
Dr. Jamalapuram Harigopal Chairman & Ind.Director
Mr. Santosh Varalwar Managing Director
Dr. Manohar Rao Varalwar Whole Time Director
Mr. Sandeep Varalwar Whole Time Director
Mr. Subhash Varalwar Non Executive Director

Vivimed Labs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Vivimed Labs FAQs

What is Share Price of Vivimed Labs ?

Vivimed Labs share price is ₹6 As on 22 March, 2023 | 21:50

What is the Market Cap of Vivimed Labs ?

The Market Cap of Vivimed Labs is ₹57.6 Cr As on 22 March, 2023 | 21:50

What is the P/E ratio of Vivimed Labs ?

The P/E ratio of Vivimed Labs is -0.7 As on 22 March, 2023 | 21:50

What is the PB ratio of Vivimed Labs ?

The PB ratio of Vivimed Labs is 0.2 As on 22 March, 2023 | 21:50

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number